Burden and economic cost of group A streptococcal pharyngitis

Elizabeth Pfoh1, Michael R Wessels, Donald Goldmann

  • 1Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Ave, Boston, MA 02215, USA.

Pediatrics
|February 5, 2008
PubMed

Insights

Group A streptococcal pharyngitis in children incurs significant societal costs, with nonmedical expenses comprising nearly half. This common childhood illness results in substantial economic burden due to missed school and parental workdays.

Area of Science:

  • Pediatric infectious diseases
  • Public health economics
  • Healthcare management

Background:

  • Group A streptococcal pharyngitis (GASP) is a common bacterial infection in school-aged children.
  • Understanding the full economic impact of GASP is crucial for resource allocation and public health initiatives.

Purpose of the Study:

  • To quantify the morbidity, medical costs, and nonmedical costs associated with group A streptococcal pharyngitis in school-aged children.
  • To provide a comprehensive societal cost analysis of GASP.

Main Methods:

  • A study involving parents of children diagnosed with GASP at two pediatric practices in the Boston metropolitan area.
  • Telephone interviews were conducted to gather data on healthcare utilization, medication use, and time missed from work or school.

Main Results:

  • One hundred thirty-five parents completed interviews.
  • Children missed an average of 1.9 days of school/daycare; 42% of parents missed an average of 1.8 workdays.
  • The total societal cost per case was $205, with nonmedical costs accounting for $87.

Conclusions:

  • The societal cost of group A streptococcal pharyngitis is substantial, with a significant portion attributed to nonmedical expenses.
  • Extrapolated annual costs in the United States range from $224 to $539 million.
  • These findings highlight the considerable economic burden of GASP beyond direct medical expenses.
Abstract

Related Concept Videos

Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...